bringing relief to millions worldwide.
By the Numbers
Skin diseases are among the most common health issues worldwide. In addition to the physical discomfort, these condition can have a profound impact on a person’s overall quality of life and increase the risk of depression.
Americans have sought treatment for at least one skin disease
People worldwide suffer from psoriasis
Americans over the age of 65 have a skin disease
The Why
Clinical research has been instrumental in driving innovations in the treatment landscape for conditions like eczema and psoriasis. HRHR has conducted research on targeted therapies designed to alleviate symptoms and improve patients’ quality of life.
Results
- Dupilumab for eczema treatment approved March 2017
Interested in joining a trial?